

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * complement activation (GO:0006956) | 9.98973023 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 8.92843071 |
| 3 | B cell receptor signaling pathway (GO:0050853) | 8.21940636 |
| 4 | positive regulation of respiratory burst (GO:0060267) | 8.11053403 |
| 5 | glomerular filtration (GO:0003094) | 6.87234256 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.81483507 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.81483507 |
| 8 | * immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 6.59294798 |
| 9 | * Fc-gamma receptor signaling pathway (GO:0038094) | 6.59294798 |
| 10 | * Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 6.59294798 |
| 11 | negative regulation of glucose import (GO:0046325) | 6.55807233 |
| 12 | * Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 6.49917847 |
| 13 | * protein activation cascade (GO:0072376) | 6.32769804 |
| 14 | renal filtration (GO:0097205) | 6.21601023 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.09098960 |
| 16 | * humoral immune response (GO:0006959) | 5.99377125 |
| 17 | negative regulation of B cell proliferation (GO:0030889) | 5.85595266 |
| 18 | cytidine deamination (GO:0009972) | 5.79163731 |
| 19 | cytidine metabolic process (GO:0046087) | 5.79163731 |
| 20 | cytidine catabolic process (GO:0006216) | 5.79163731 |
| 21 | signal peptide processing (GO:0006465) | 5.59231213 |
| 22 | retina homeostasis (GO:0001895) | 5.57214539 |
| 23 | cellular response to zinc ion (GO:0071294) | 5.50652553 |
| 24 | regulation of respiratory burst (GO:0060263) | 5.47699879 |
| 25 | regulation of B cell proliferation (GO:0030888) | 5.39645278 |
| 26 | negative regulation of glucose transport (GO:0010829) | 5.36684183 |
| 27 | regulation of B cell differentiation (GO:0045577) | 5.33698291 |
| 28 | positive regulation of B cell differentiation (GO:0045579) | 5.29007646 |
| 29 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 5.04633828 |
| 30 | B cell proliferation (GO:0042100) | 4.98825857 |
| 31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.98724730 |
| 32 | * immune response-activating cell surface receptor signaling pathway (GO:0002429) | 4.88004748 |
| 33 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.81015066 |
| 34 | regulation of cellular extravasation (GO:0002691) | 4.68428137 |
| 35 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.45928815 |
| 36 | regulation of antigen processing and presentation (GO:0002577) | 4.32435037 |
| 37 | detection of bacterium (GO:0016045) | 4.28800895 |
| 38 | mature B cell differentiation (GO:0002335) | 4.28657632 |
| 39 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.27971036 |
| 40 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 4.25857852 |
| 41 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 4.25857852 |
| 42 | positive regulation of immunoglobulin production (GO:0002639) | 4.16511359 |
| 43 | detection of other organism (GO:0098543) | 4.11607410 |
| 44 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.00826369 |
| 45 | regulation of B cell apoptotic process (GO:0002902) | 3.94293432 |
| 46 | regulation of B cell activation (GO:0050864) | 3.86578566 |
| 47 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.84343471 |
| 48 | angiotensin maturation (GO:0002003) | 3.80788263 |
| 49 | respiratory burst (GO:0045730) | 3.79937144 |
| 50 | negative regulation of cell killing (GO:0031342) | 3.74425736 |
| 51 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.74425736 |
| 52 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.69575903 |
| 53 | mature B cell differentiation involved in immune response (GO:0002313) | 3.67715592 |
| 54 | positive thymic T cell selection (GO:0045059) | 3.67438135 |
| 55 | B cell homeostasis (GO:0001782) | 3.67367746 |
| 56 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.65320547 |
| 57 | negative thymic T cell selection (GO:0045060) | 3.62869756 |
| 58 | positive regulation of Rap GTPase activity (GO:0032854) | 3.62393805 |
| 59 | positive regulation of pseudopodium assembly (GO:0031274) | 3.61713470 |
| 60 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.61163226 |
| 61 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.54707265 |
| 62 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.52104538 |
| 63 | cellular response to type I interferon (GO:0071357) | 3.49112293 |
| 64 | type I interferon signaling pathway (GO:0060337) | 3.49112293 |
| 65 | B cell activation (GO:0042113) | 3.48198850 |
| 66 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.47911098 |
| 67 | response to type I interferon (GO:0034340) | 3.47500635 |
| 68 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.46282041 |
| 69 | positive regulation of B cell proliferation (GO:0030890) | 3.44141005 |
| 70 | * immune response-activating signal transduction (GO:0002757) | 3.43415321 |
| 71 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.39325981 |
| 72 | antimicrobial humoral response (GO:0019730) | 3.38242068 |
| 73 | negative regulation of B cell apoptotic process (GO:0002903) | 3.37477513 |
| 74 | B cell mediated immunity (GO:0019724) | 3.36270944 |
| 75 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.35386543 |
| 76 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 3.33952401 |
| 77 | antibacterial humoral response (GO:0019731) | 3.32757662 |
| 78 | natural killer cell mediated immunity (GO:0002228) | 3.30130356 |
| 79 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.30130356 |
| 80 | negative T cell selection (GO:0043383) | 3.29514721 |
| 81 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.27473097 |
| 82 | regulation of gamma-delta T cell activation (GO:0046643) | 3.22659111 |
| 83 | regulation of pseudopodium assembly (GO:0031272) | 3.21879344 |
| 84 | positive regulation of B cell activation (GO:0050871) | 3.20164223 |
| 85 | immunoglobulin mediated immune response (GO:0016064) | 3.18683150 |
| 86 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.17634210 |
| 87 | cellular response to interferon-gamma (GO:0071346) | 3.16621741 |
| 88 | * immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 3.16620698 |
| 89 | positive regulation of macrophage cytokine production (GO:0060907) | 3.13175427 |
| 90 | regulation of immunoglobulin production (GO:0002637) | 3.12699550 |
| 91 | thymic T cell selection (GO:0045061) | 3.11250792 |
| 92 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.10938439 |
| 93 | chronic inflammatory response (GO:0002544) | 3.10743462 |
| 94 | germinal center formation (GO:0002467) | 3.09841548 |
| 95 | * activation of immune response (GO:0002253) | 3.09010819 |
| 96 | negative regulation of B cell activation (GO:0050869) | 3.08945926 |
| 97 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.07762836 |
| 98 | L-fucose catabolic process (GO:0042355) | 3.04694544 |
| 99 | fucose catabolic process (GO:0019317) | 3.04694544 |
| 100 | L-fucose metabolic process (GO:0042354) | 3.04694544 |
| 101 | defense response to protozoan (GO:0042832) | 3.04299948 |
| 102 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.02334375 |
| 103 | positive regulation by symbiont of host defense response (GO:0052509) | 2.99738789 |
| 104 | modulation by symbiont of host defense response (GO:0052031) | 2.99738789 |
| 105 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.99738789 |
| 106 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.99738789 |
| 107 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.99738789 |
| 108 | modulation by symbiont of host immune response (GO:0052553) | 2.99738789 |
| 109 | response to interferon-gamma (GO:0034341) | 2.99095235 |
| 110 | detection of external biotic stimulus (GO:0098581) | 2.98898759 |
| 111 | regulation of Rap GTPase activity (GO:0032317) | 2.98879447 |
| 112 | dendritic cell chemotaxis (GO:0002407) | 2.98641684 |
| 113 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.98567262 |
| 114 | lymphocyte homeostasis (GO:0002260) | 2.97138098 |
| 115 | T cell selection (GO:0045058) | 2.94093369 |
| 116 | B cell activation involved in immune response (GO:0002312) | 2.93546407 |
| 117 | NIK/NF-kappaB signaling (GO:0038061) | 2.93271089 |
| 118 | peptide catabolic process (GO:0043171) | 2.89859108 |
| 119 | positive regulation of protein homooligomerization (GO:0032464) | 2.89005871 |
| 120 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.88964559 |
| 121 | myeloid dendritic cell differentiation (GO:0043011) | 2.86423865 |
| 122 | positive regulation of production of molecular mediator of immune response (GO:0002702) | 2.84335943 |
| 123 | * Fc receptor signaling pathway (GO:0038093) | 2.83788136 |
| 124 | adhesion of symbiont to host cell (GO:0044650) | 2.83702697 |
| 125 | virion attachment to host cell (GO:0019062) | 2.83702697 |
| 126 | T-helper 1 type immune response (GO:0042088) | 2.83528975 |
| 127 | negative regulation of cellular response to insulin stimulus (GO:1900077) | 2.81247253 |
| 128 | * Fc-epsilon receptor signaling pathway (GO:0038095) | 2.81057009 |
| 129 | surfactant homeostasis (GO:0043129) | 2.80245840 |
| 130 | macrophage activation involved in immune response (GO:0002281) | 2.80183491 |
| 131 | eosinophil chemotaxis (GO:0048245) | 2.79527894 |
| 132 | positive regulation of T cell migration (GO:2000406) | 2.79500062 |
| 133 | response to interleukin-15 (GO:0070672) | 2.79355336 |
| 134 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.78735450 |
| 135 | regulation of integrin activation (GO:0033623) | 2.78710216 |
| 136 | positive regulation of antigen processing and presentation (GO:0002579) | 2.78140703 |
| 137 | T cell costimulation (GO:0031295) | 2.78083550 |
| 138 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.77323877 |
| 139 | phenylpropanoid metabolic process (GO:0009698) | 2.76799320 |
| 140 | lymphocyte proliferation (GO:0046651) | 2.75275336 |
| 141 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.74709216 |
| 142 | production of molecular mediator of immune response (GO:0002440) | 2.74185010 |
| 143 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.73883832 |
| 144 | lymphocyte costimulation (GO:0031294) | 2.73877727 |
| 145 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.73047333 |
| 146 | I-kappaB phosphorylation (GO:0007252) | 2.72556128 |
| 147 | regulation of T cell migration (GO:2000404) | 2.69735804 |
| 148 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.67162486 |
| 149 | regulation of T cell tolerance induction (GO:0002664) | 2.65126783 |
| 150 | myeloid dendritic cell activation (GO:0001773) | 2.63732318 |
| 151 | regulation of guanylate cyclase activity (GO:0031282) | 2.62844354 |
| 152 | positive regulation of neutrophil migration (GO:1902624) | 2.60026787 |
| 153 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.60026787 |
| 154 | intestinal absorption (GO:0050892) | 2.58285341 |
| 155 | eosinophil migration (GO:0072677) | 2.56695261 |
| 156 | GDP-mannose metabolic process (GO:0019673) | 2.51957422 |
| 157 | positive regulation of lymphocyte migration (GO:2000403) | 2.51659686 |
| 158 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.51397921 |
| 159 | detection of biotic stimulus (GO:0009595) | 2.51302398 |
| 160 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.50682807 |
| 161 | defense response to Gram-negative bacterium (GO:0050829) | 2.45750902 |
| 162 | dendritic cell migration (GO:0036336) | 2.45335643 |
| 163 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.44995655 |
| 164 | adhesion of symbiont to host (GO:0044406) | 2.41514509 |
| 165 | protein-chromophore linkage (GO:0018298) | 2.40177442 |
| 166 | interferon-gamma secretion (GO:0072643) | 2.40054298 |
| 167 | response to nitric oxide (GO:0071731) | 2.39053727 |
| 168 | * complement activation, classical pathway (GO:0006958) | 13.2088654 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.86516949 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.24402978 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.13443140 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.07724976 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.50829712 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 4.44018448 |
| 7 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 4.28264985 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.74884283 |
| 9 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.59715910 |
| 10 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.39488643 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.24493846 |
| 12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.08368495 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.89849578 |
| 14 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.84642634 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.80643600 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.79444242 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.55887765 |
| 18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.47316644 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.43968871 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.42146029 |
| 21 | MYB_26560356_Chip-Seq_TH1_Human | 2.31463012 |
| 22 | MYB_26560356_Chip-Seq_TH2_Human | 2.30905366 |
| 23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.26995477 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.22783642 |
| 25 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.12581210 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.09794550 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.04795021 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.99864703 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 1.97134608 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.95507575 |
| 31 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.93638689 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.90853542 |
| 33 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.88347056 |
| 34 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.86725473 |
| 35 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.82305382 |
| 36 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.81977380 |
| 37 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.80629296 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.79430122 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.75253473 |
| 40 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.74675771 |
| 41 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.74032453 |
| 42 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.73213570 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68665640 |
| 44 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.65029507 |
| 45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64514898 |
| 46 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.61812504 |
| 47 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.58472646 |
| 48 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.57522774 |
| 49 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.56109105 |
| 50 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.54856071 |
| 51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.52605097 |
| 52 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.50798307 |
| 53 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.50463819 |
| 54 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.48654318 |
| 55 | MAF_26560356_Chip-Seq_TH2_Human | 1.48265247 |
| 56 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.47802878 |
| 57 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.47426777 |
| 58 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.46692442 |
| 59 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.44705669 |
| 60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.42547685 |
| 61 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41623813 |
| 62 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.38445279 |
| 63 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38080625 |
| 64 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.36824008 |
| 65 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36594615 |
| 66 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.36554710 |
| 67 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36112532 |
| 68 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.35673503 |
| 69 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.34717640 |
| 70 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34174817 |
| 71 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.33930280 |
| 72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.33692121 |
| 73 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.33240086 |
| 74 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.30398952 |
| 75 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.28345845 |
| 76 | SPI1_23127762_ChIP-Seq_K562_Human | 1.26732742 |
| 77 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.26724236 |
| 78 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.26251554 |
| 79 | GATA3_26560356_Chip-Seq_TH2_Human | 1.25127870 |
| 80 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.24080608 |
| 81 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.20343379 |
| 82 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.19267431 |
| 83 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.18965916 |
| 84 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18112854 |
| 85 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.17166312 |
| 86 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.16400578 |
| 87 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.16019386 |
| 88 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15541869 |
| 89 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.15032057 |
| 90 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.14673632 |
| 91 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.14126175 |
| 92 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.13481419 |
| 93 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.12394132 |
| 94 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12009234 |
| 95 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.10589826 |
| 96 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09111338 |
| 97 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08745826 |
| 98 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08152516 |
| 99 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.07845784 |
| 100 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.06572355 |
| 101 | GATA1_22025678_ChIP-Seq_K562_Human | 1.06508246 |
| 102 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.06332230 |
| 103 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.05786661 |
| 104 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.05093399 |
| 105 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.04561767 |
| 106 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03308152 |
| 107 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.03141433 |
| 108 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.01103701 |
| 109 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.01063064 |
| 110 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00814143 |
| 111 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.99586548 |
| 112 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.99029597 |
| 113 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.99005561 |
| 114 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.96911947 |
| 115 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96902149 |
| 116 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96673786 |
| 117 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.96561131 |
| 118 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.95694797 |
| 119 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.95662768 |
| 120 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95262410 |
| 121 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.94837197 |
| 122 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94505045 |
| 123 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94483643 |
| 124 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93377335 |
| 125 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.93351488 |
| 126 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.92409100 |
| 127 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.90581751 |
| 128 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90108848 |
| 129 | P300_27268052_Chip-Seq_Bcells_Human | 0.90004993 |
| 130 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88421538 |
| 131 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88346922 |
| 132 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87701292 |
| 133 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.86796130 |
| 134 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.85963443 |
| 135 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.84720026 |
| 136 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84480473 |
| 137 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84469511 |
| 138 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.83038016 |
| 139 | GATA3_26560356_Chip-Seq_TH1_Human | 0.82867725 |
| 140 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.82653966 |
| 141 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82520444 |
| 142 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.81267930 |
| 143 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.81091413 |
| 144 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79028104 |
| 145 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.78887396 |
| 146 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78040576 |
| 147 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.76285412 |
| 148 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.75736697 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 6.57171560 |
| 2 | MP0001800_abnormal_humoral_immune | 5.20862644 |
| 3 | MP0001790_abnormal_immune_system | 4.64323185 |
| 4 | MP0005387_immune_system_phenotype | 4.64323185 |
| 5 | MP0003724_increased_susceptibility_to | 4.08912325 |
| 6 | MP0002452_abnormal_antigen_presenting | 3.88118625 |
| 7 | MP0003303_peritoneal_inflammation | 3.87542748 |
| 8 | MP0005671_abnormal_response_to | 3.71370236 |
| 9 | MP0000685_abnormal_immune_system | 3.53520483 |
| 10 | MP0002723_abnormal_immune_serum | 3.25345117 |
| 11 | MP0002420_abnormal_adaptive_immunity | 3.16537117 |
| 12 | MP0005000_abnormal_immune_tolerance | 3.10657278 |
| 13 | MP0001819_abnormal_immune_cell | 3.08378444 |
| 14 | MP0002398_abnormal_bone_marrow | 2.93729005 |
| 15 | MP0000716_abnormal_immune_system | 2.77965188 |
| 16 | MP0000689_abnormal_spleen_morphology | 2.62563895 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.49953934 |
| 18 | MP0005025_abnormal_response_to | 2.34716167 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.32149755 |
| 20 | MP0002166_altered_tumor_susceptibility | 2.31837332 |
| 21 | MP0002429_abnormal_blood_cell | 2.30197095 |
| 22 | MP0003763_abnormal_thymus_physiology | 2.21491164 |
| 23 | MP0010234_abnormal_vibrissa_follicle | 2.20104348 |
| 24 | MP0002722_abnormal_immune_system | 2.13394535 |
| 25 | MP0005166_decreased_susceptibility_to | 2.01831600 |
| 26 | MP0002419_abnormal_innate_immunity | 1.96356551 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.95674359 |
| 28 | MP0005360_urolithiasis | 1.91244119 |
| 29 | MP0004782_abnormal_surfactant_physiolog | 1.90219248 |
| 30 | MP0009785_altered_susceptibility_to | 1.89362315 |
| 31 | MP0004264_abnormal_extraembryonic_tissu | 1.87600195 |
| 32 | MP0001879_abnormal_lymphatic_vessel | 1.86619454 |
| 33 | MP0005275_abnormal_skin_tensile | 1.86429583 |
| 34 | MP0006054_spinal_hemorrhage | 1.82588111 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.81371197 |
| 36 | MP0002139_abnormal_hepatobiliary_system | 1.77684708 |
| 37 | MP0002006_tumorigenesis | 1.74787973 |
| 38 | MP0004858_abnormal_nervous_system | 1.70819289 |
| 39 | MP0003436_decreased_susceptibility_to | 1.70429003 |
| 40 | MP0005310_abnormal_salivary_gland | 1.69772520 |
| 41 | MP0004947_skin_inflammation | 1.69236739 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.64445546 |
| 43 | MP0002405_respiratory_system_inflammati | 1.61677013 |
| 44 | MP0009840_abnormal_foam_cell | 1.55478262 |
| 45 | MP0003693_abnormal_embryo_hatching | 1.55015605 |
| 46 | MP0002796_impaired_skin_barrier | 1.53584614 |
| 47 | MP0004510_myositis | 1.52803209 |
| 48 | MP0009333_abnormal_splenocyte_physiolog | 1.52635750 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.50917481 |
| 50 | MP0002933_joint_inflammation | 1.45932396 |
| 51 | MP0001666_abnormal_nutrient_absorption | 1.44125090 |
| 52 | MP0001853_heart_inflammation | 1.43863666 |
| 53 | MP0001873_stomach_inflammation | 1.41899108 |
| 54 | MP0000703_abnormal_thymus_morphology | 1.39257272 |
| 55 | MP0008438_abnormal_cutaneous_collagen | 1.35264107 |
| 56 | MP0003866_abnormal_defecation | 1.33357035 |
| 57 | MP0002396_abnormal_hematopoietic_system | 1.25787581 |
| 58 | MP0002019_abnormal_tumor_incidence | 1.25417760 |
| 59 | MP0003448_altered_tumor_morphology | 1.25173663 |
| 60 | MP0008004_abnormal_stomach_pH | 1.24433933 |
| 61 | MP0003075_altered_response_to | 1.23141862 |
| 62 | MP0000490_abnormal_crypts_of | 1.12060263 |
| 63 | MP0005085_abnormal_gallbladder_physiolo | 1.11879655 |
| 64 | MP0000604_amyloidosis | 1.09967174 |
| 65 | MP0005464_abnormal_platelet_physiology | 1.07815391 |
| 66 | MP0000465_gastrointestinal_hemorrhage | 1.06618176 |
| 67 | MP0002136_abnormal_kidney_physiology | 1.04306776 |
| 68 | MP0000343_altered_response_to | 1.04285694 |
| 69 | MP0006082_CNS_inflammation | 1.04086730 |
| 70 | MP0002998_abnormal_bone_remodeling | 1.01771943 |
| 71 | MP0005409_darkened_coat_color | 1.00710357 |
| 72 | MP0003183_abnormal_peptide_metabolism | 0.99574030 |
| 73 | MP0003453_abnormal_keratinocyte_physiol | 0.98922709 |
| 74 | MP0010094_abnormal_chromosome_stability | 0.97863835 |
| 75 | MP0005503_abnormal_tendon_morphology | 0.97106287 |
| 76 | MP0001664_abnormal_digestion | 0.97045038 |
| 77 | MP0008057_abnormal_DNA_replication | 0.94871562 |
| 78 | MP0005390_skeleton_phenotype | 0.91115634 |
| 79 | MP0001851_eye_inflammation | 0.90966295 |
| 80 | MP0000249_abnormal_blood_vessel | 0.90868752 |
| 81 | MP0009278_abnormal_bone_marrow | 0.89927479 |
| 82 | MP0008469_abnormal_protein_level | 0.89004417 |
| 83 | MP0004808_abnormal_hematopoietic_stem | 0.88893935 |
| 84 | MP0003329_amyloid_beta_deposits | 0.87856389 |
| 85 | MP0008260_abnormal_autophagy | 0.87404249 |
| 86 | MP0003077_abnormal_cell_cycle | 0.86401914 |
| 87 | MP0004019_abnormal_vitamin_homeostasis | 0.86242537 |
| 88 | MP0009379_abnormal_foot_pigmentation | 0.86164362 |
| 89 | MP0003279_aneurysm | 0.84022110 |
| 90 | MP0001958_emphysema | 0.82699811 |
| 91 | MP0010352_gastrointestinal_tract_polyps | 0.82148058 |
| 92 | MP0005365_abnormal_bile_salt | 0.81839321 |
| 93 | MP0002277_abnormal_respiratory_mucosa | 0.81187628 |
| 94 | MP0005164_abnormal_response_to | 0.80420308 |
| 95 | MP0000003_abnormal_adipose_tissue | 0.78894311 |
| 96 | MP0001216_abnormal_epidermal_layer | 0.78602753 |
| 97 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.76956792 |
| 98 | MP0005165_increased_susceptibility_to | 0.75930835 |
| 99 | MP0003806_abnormal_nucleotide_metabolis | 0.74479904 |
| 100 | MP0001663_abnormal_digestive_system | 0.73476414 |
| 101 | MP0004957_abnormal_blastocyst_morpholog | 0.72553677 |
| 102 | MP0003045_fibrosis | 0.72155850 |
| 103 | MP0000678_abnormal_parathyroid_gland | 0.72065134 |
| 104 | MP0003868_abnormal_feces_composition | 0.71324557 |
| 105 | MP0002133_abnormal_respiratory_system | 0.70437674 |
| 106 | MP0002693_abnormal_pancreas_physiology | 0.70010942 |
| 107 | MP0001191_abnormal_skin_condition | 0.69954971 |
| 108 | MP0005451_abnormal_body_composition | 0.66405663 |
| 109 | MP0003656_abnormal_erythrocyte_physiolo | 0.62164063 |
| 110 | MP0005397_hematopoietic_system_phenotyp | 0.61491635 |
| 111 | MP0001545_abnormal_hematopoietic_system | 0.61491635 |
| 112 | MP0000609_abnormal_liver_physiology | 0.61302019 |
| 113 | MP0002083_premature_death | 0.59985771 |
| 114 | MP0002168_other_aberrant_phenotype | 0.59747000 |
| 115 | MP0005023_abnormal_wound_healing | 0.54338973 |
| 116 | MP0005076_abnormal_cell_differentiation | 0.53989495 |
| 117 | MP0009643_abnormal_urine_homeostasis | 0.53597511 |
| 118 | MP0002876_abnormal_thyroid_physiology | 0.53595388 |
| 119 | MP0001533_abnormal_skeleton_physiology | 0.53508314 |
| 120 | MP0001919_abnormal_reproductive_system | 0.52638702 |
| 121 | MP0000477_abnormal_intestine_morphology | 0.51739787 |
| 122 | MP0000350_abnormal_cell_proliferation | 0.50436941 |
| 123 | MP0005058_abnormal_lysosome_morphology | 0.48857738 |
| 124 | MP0000013_abnormal_adipose_tissue | 0.48797624 |
| 125 | MP0009764_decreased_sensitivity_to | 0.48612233 |
| 126 | MP0000313_abnormal_cell_death | 0.48610919 |
| 127 | MP0001944_abnormal_pancreas_morphology | 0.46596815 |
| 128 | MP0009763_increased_sensitivity_to | 0.45711711 |
| 129 | MP0001730_embryonic_growth_arrest | 0.44909278 |
| 130 | MP0009931_abnormal_skin_appearance | 0.44624744 |
| 131 | MP0005621_abnormal_cell_physiology | 0.44420904 |
| 132 | MP0003195_calcinosis | 0.42906817 |
| 133 | MP0003828_pulmonary_edema | 0.40910411 |
| 134 | MP0002169_no_abnormal_phenotype | 0.39810764 |
| 135 | MP0002873_normal_phenotype | 0.39531830 |
| 136 | MP0008874_decreased_physiological_sensi | 0.39388313 |
| 137 | MP0003091_abnormal_cell_migration | 0.38765459 |
| 138 | MP0000858_altered_metastatic_potential | 0.38596960 |
| 139 | MP0000639_abnormal_adrenal_gland | 0.37512010 |
| 140 | MP0002909_abnormal_adrenal_gland | 0.36463878 |
| 141 | MP0002135_abnormal_kidney_morphology | 0.35427457 |
| 142 | MP0005381_digestive/alimentary_phenotyp | 0.35316127 |
| 143 | MP0003943_abnormal_hepatobiliary_system | 0.35281452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bronchitis (HP:0002837) | 7.76098517 |
| 2 | Recurrent sinusitis (HP:0011108) | 7.58005093 |
| 3 | Gastrointestinal stroma tumor (HP:0100723) | 7.46089919 |
| 4 | Abnormality of B cell number (HP:0010975) | 7.04640812 |
| 5 | B lymphocytopenia (HP:0010976) | 7.04640812 |
| 6 | Colitis (HP:0002583) | 6.96615396 |
| 7 | Cellulitis (HP:0100658) | 6.91818473 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 6.33001565 |
| 9 | Papilloma (HP:0012740) | 6.14523030 |
| 10 | Verrucae (HP:0200043) | 6.14523030 |
| 11 | IgM deficiency (HP:0002850) | 5.86446328 |
| 12 | Recurrent pneumonia (HP:0006532) | 5.42040136 |
| 13 | Inflammation of the large intestine (HP:0002037) | 5.32254269 |
| 14 | Recurrent viral infections (HP:0004429) | 5.30970386 |
| 15 | Chronic sinusitis (HP:0011109) | 5.28389264 |
| 16 | Meningitis (HP:0001287) | 5.20678978 |
| 17 | Malnutrition (HP:0004395) | 5.09761547 |
| 18 | Gastrointestinal inflammation (HP:0004386) | 5.07591127 |
| 19 | Recurrent lower respiratory tract infections (HP:0002783) | 4.80406763 |
| 20 | Emphysema (HP:0002097) | 4.59973423 |
| 21 | Bronchitis (HP:0012387) | 4.59849710 |
| 22 | Osteomyelitis (HP:0002754) | 4.35163923 |
| 23 | Chronic otitis media (HP:0000389) | 4.33124044 |
| 24 | Recurrent otitis media (HP:0000403) | 4.29064622 |
| 25 | Prostate neoplasm (HP:0100787) | 4.23955279 |
| 26 | Lymphopenia (HP:0001888) | 4.17102716 |
| 27 | IgA deficiency (HP:0002720) | 4.16092446 |
| 28 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.02189019 |
| 29 | Abnormality of complement system (HP:0005339) | 3.96295077 |
| 30 | IgG deficiency (HP:0004315) | 3.78724126 |
| 31 | Vasculitis (HP:0002633) | 3.74402877 |
| 32 | Glomerulonephritis (HP:0000099) | 3.74119379 |
| 33 | Complement deficiency (HP:0004431) | 3.66469984 |
| 34 | Panhypogammaglobulinemia (HP:0003139) | 3.64467166 |
| 35 | Sepsis (HP:0100806) | 3.61346404 |
| 36 | Thyroiditis (HP:0100646) | 3.50607113 |
| 37 | Restrictive lung disease (HP:0002091) | 3.50026899 |
| 38 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.44320697 |
| 39 | Skin rash (HP:0000988) | 3.33067176 |
| 40 | Abnormality of the prostate (HP:0008775) | 3.32510358 |
| 41 | Interstitial pulmonary disease (HP:0006530) | 3.28111845 |
| 42 | Abnormality of T cell physiology (HP:0011840) | 3.25672294 |
| 43 | Recurrent abscess formation (HP:0002722) | 3.21633754 |
| 44 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.13984640 |
| 45 | Nephritis (HP:0000123) | 3.07698576 |
| 46 | Premature loss of primary teeth (HP:0006323) | 3.06048783 |
| 47 | Recurrent bacterial skin infections (HP:0005406) | 3.00259325 |
| 48 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.96161136 |
| 49 | Spontaneous hematomas (HP:0007420) | 2.93774307 |
| 50 | Recurrent fungal infections (HP:0002841) | 2.92101941 |
| 51 | Abnormality of T cells (HP:0002843) | 2.83099595 |
| 52 | Gastrointestinal infarctions (HP:0005244) | 2.78692246 |
| 53 | Leukopenia (HP:0001882) | 2.73165399 |
| 54 | Gingivitis (HP:0000230) | 2.72343502 |
| 55 | Alopecia of scalp (HP:0002293) | 2.63172092 |
| 56 | Recurrent skin infections (HP:0001581) | 2.55610752 |
| 57 | Neutropenia (HP:0001875) | 2.53112820 |
| 58 | Nasal polyposis (HP:0100582) | 2.51933382 |
| 59 | Small epiphyses (HP:0010585) | 2.50611842 |
| 60 | Mediastinal lymphadenopathy (HP:0100721) | 2.49989268 |
| 61 | Orchitis (HP:0100796) | 2.47548871 |
| 62 | Autoimmune thrombocytopenia (HP:0001973) | 2.47064558 |
| 63 | Lymphoma (HP:0002665) | 2.44986623 |
| 64 | Recurrent cutaneous fungal infections (HP:0011370) | 2.43846521 |
| 65 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.43846521 |
| 66 | Hemoptysis (HP:0002105) | 2.41988678 |
| 67 | Leukocytosis (HP:0001974) | 2.41555766 |
| 68 | Thrombocytosis (HP:0001894) | 2.39008228 |
| 69 | Hyperactive renin-angiotensin system (HP:0000841) | 2.38657927 |
| 70 | Eczematoid dermatitis (HP:0000976) | 2.37237793 |
| 71 | Abnormality of T cell number (HP:0011839) | 2.35677664 |
| 72 | Myositis (HP:0100614) | 2.35455194 |
| 73 | Skin ulcer (HP:0200042) | 2.35445835 |
| 74 | Mitral stenosis (HP:0001718) | 2.34625219 |
| 75 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.30933985 |
| 76 | Pulmonary infiltrates (HP:0002113) | 2.25104350 |
| 77 | Bronchiectasis (HP:0002110) | 2.22612906 |
| 78 | T lymphocytopenia (HP:0005403) | 2.20736754 |
| 79 | Basal cell carcinoma (HP:0002671) | 2.16347108 |
| 80 | Erythema (HP:0010783) | 2.15484613 |
| 81 | Right ventricular cardiomyopathy (HP:0011663) | 2.15186347 |
| 82 | Purpura (HP:0000979) | 2.10682385 |
| 83 | Ileus (HP:0002595) | 2.10143875 |
| 84 | Abnormality of the nasal mucosa (HP:0000433) | 2.09578569 |
| 85 | Viral hepatitis (HP:0006562) | 2.07693504 |
| 86 | Hemorrhage of the eye (HP:0011885) | 2.06707733 |
| 87 | Chest pain (HP:0100749) | 2.01806605 |
| 88 | Arthralgia (HP:0002829) | 2.00476189 |
| 89 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.00228783 |
| 90 | Polycythemia (HP:0001901) | 2.00184418 |
| 91 | Agammaglobulinemia (HP:0004432) | 10.7239896 |
| 92 | Combined immunodeficiency (HP:0005387) | 1.98917894 |
| 93 | Urticaria (HP:0001025) | 1.97612981 |
| 94 | Decreased circulating renin level (HP:0003351) | 1.94946719 |
| 95 | Retrobulbar optic neuritis (HP:0100654) | 1.93684404 |
| 96 | Optic neuritis (HP:0100653) | 1.93684404 |
| 97 | Abnormal hair laboratory examination (HP:0003328) | 1.93207752 |
| 98 | Pustule (HP:0200039) | 1.92988737 |
| 99 | Hypermelanotic macule (HP:0001034) | 1.92273500 |
| 100 | Encephalitis (HP:0002383) | 1.91818134 |
| 101 | Dehydration (HP:0001944) | 1.90528548 |
| 102 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.89786897 |
| 103 | Ankyloglossia (HP:0010296) | 1.89522840 |
| 104 | Abnormality of male internal genitalia (HP:0000022) | 1.89332641 |
| 105 | Obstructive lung disease (HP:0006536) | 1.89024178 |
| 106 | Chronic obstructive pulmonary disease (HP:0006510) | 1.89024178 |
| 107 | Palmoplantar hyperkeratosis (HP:0000972) | 1.85861245 |
| 108 | Abnormality of the pleura (HP:0002103) | 1.85393381 |
| 109 | Alkalosis (HP:0001948) | 1.85128970 |
| 110 | Neoplasm of the lung (HP:0100526) | 1.82424204 |
| 111 | Squamous cell carcinoma (HP:0002860) | 1.82311395 |
| 112 | Abnormality of the fingertips (HP:0001211) | 1.81050019 |
| 113 | Increased IgM level (HP:0003496) | 1.80979125 |
| 114 | Keratoconjunctivitis sicca (HP:0001097) | 1.80192403 |
| 115 | Increased IgE level (HP:0003212) | 1.78393111 |
| 116 | Plantar hyperkeratosis (HP:0007556) | 1.77896153 |
| 117 | Hypergammaglobulinemia (HP:0010702) | 1.73833813 |
| 118 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.73682940 |
| 119 | Chronic diarrhea (HP:0002028) | 1.72469984 |
| 120 | Severe combined immunodeficiency (HP:0004430) | 1.72188767 |
| 121 | Abnormality of macrophages (HP:0004311) | 1.71615664 |
| 122 | Teleangiectasia of the skin (HP:0100585) | 1.69245503 |
| 123 | Xerostomia (HP:0000217) | 1.68569672 |
| 124 | Onycholysis (HP:0001806) | 1.65619072 |
| 125 | Flattened epiphyses (HP:0003071) | 1.58550503 |
| 126 | Eosinophilia (HP:0001880) | 1.56957763 |
| 127 | Hypertensive crisis (HP:0100735) | 1.56515955 |
| 128 | External ear malformation (HP:0008572) | 1.55522785 |
| 129 | Acrocyanosis (HP:0001063) | 1.55286560 |
| 130 | Petechiae (HP:0000967) | 1.51256923 |
| 131 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.49957357 |
| 132 | Villous atrophy (HP:0011473) | 1.49957357 |
| 133 | Vacuolated lymphocytes (HP:0001922) | 1.49138489 |
| 134 | Microcytic anemia (HP:0001935) | 1.47000728 |
| 135 | Myocardial infarction (HP:0001658) | 1.46424931 |
| 136 | Hypoplasia of the thymus (HP:0000778) | 1.44347479 |
| 137 | Irregular vertebral endplates (HP:0003301) | 1.40987658 |
| 138 | Stomatitis (HP:0010280) | 1.40821365 |
| 139 | Mucosal telangiectasiae (HP:0100579) | 1.39331010 |
| 140 | Fatigue (HP:0012378) | 1.35697812 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 6.48063133 |
| 2 | ERN1 | 5.87396947 |
| 3 | MST1R | 3.12601072 |
| 4 | CSF1R | 3.05768575 |
| 5 | GRK6 | 3.04160635 |
| 6 | SYK | 3.00437892 |
| 7 | NME2 | 2.77950694 |
| 8 | PRPF4B | 2.77947461 |
| 9 | MAP3K13 | 2.74050371 |
| 10 | BLK | 2.73099703 |
| 11 | MAP3K10 | 2.42126411 |
| 12 | MAP3K14 | 2.41372595 |
| 13 | RIPK4 | 2.38801802 |
| 14 | RIPK1 | 2.35822387 |
| 15 | TBK1 | 2.31395778 |
| 16 | BTK | 2.27120112 |
| 17 | EPHA3 | 2.18840177 |
| 18 | TYK2 | 2.17783449 |
| 19 | KIT | 2.02559312 |
| 20 | LYN | 1.93526464 |
| 21 | EPHB1 | 1.88801018 |
| 22 | EIF2AK3 | 1.78508010 |
| 23 | STK10 | 1.69973180 |
| 24 | IRAK4 | 1.56734927 |
| 25 | IRAK3 | 1.56099453 |
| 26 | LRRK2 | 1.51993521 |
| 27 | SIK2 | 1.47150775 |
| 28 | MST4 | 1.44649064 |
| 29 | MAP3K1 | 1.43909206 |
| 30 | IKBKE | 1.43622921 |
| 31 | PRKCH | 1.34061274 |
| 32 | JAK1 | 1.32120245 |
| 33 | HCK | 1.29974496 |
| 34 | NEK2 | 1.28426625 |
| 35 | ACVR1B | 1.25630758 |
| 36 | TAOK3 | 1.25139576 |
| 37 | IKBKB | 1.21961012 |
| 38 | PIK3CA | 1.21649612 |
| 39 | ITK | 1.21581032 |
| 40 | PRKCQ | 1.20674556 |
| 41 | SMG1 | 1.18925206 |
| 42 | EPHA2 | 1.16149973 |
| 43 | PRKG2 | 1.13660370 |
| 44 | TEC | 1.12284874 |
| 45 | TXK | 1.11819480 |
| 46 | JAK3 | 1.11581527 |
| 47 | MAP3K9 | 1.11362826 |
| 48 | PTK6 | 1.02023046 |
| 49 | IRAK1 | 1.01236845 |
| 50 | ARAF | 1.01084728 |
| 51 | FES | 1.00988337 |
| 52 | LCK | 1.00861682 |
| 53 | MATK | 1.00376479 |
| 54 | EEF2K | 0.99560334 |
| 55 | CSK | 0.98797933 |
| 56 | PIM1 | 0.95244934 |
| 57 | PDGFRA | 0.93115063 |
| 58 | GRK1 | 0.93008986 |
| 59 | MAP3K3 | 0.92314591 |
| 60 | MET | 0.90021169 |
| 61 | EIF2AK1 | 0.86906074 |
| 62 | FER | 0.86160801 |
| 63 | PRKCI | 0.85666432 |
| 64 | DDR2 | 0.85125648 |
| 65 | TESK2 | 0.84688485 |
| 66 | PKN2 | 0.81906181 |
| 67 | TAOK1 | 0.81489969 |
| 68 | STK24 | 0.80646512 |
| 69 | SIK3 | 0.79491346 |
| 70 | CLK1 | 0.77530398 |
| 71 | FGFR3 | 0.75827149 |
| 72 | MAP3K11 | 0.75528287 |
| 73 | HIPK2 | 0.74725401 |
| 74 | RPS6KA4 | 0.74348081 |
| 75 | NEK9 | 0.72595846 |
| 76 | PDPK1 | 0.72193850 |
| 77 | MARK3 | 0.71624728 |
| 78 | ZAP70 | 0.70758466 |
| 79 | EPHB2 | 0.70691415 |
| 80 | MAP2K2 | 0.69989704 |
| 81 | NLK | 0.69583957 |
| 82 | FRK | 0.69571830 |
| 83 | TGFBR2 | 0.67604036 |
| 84 | BUB1 | 0.67598229 |
| 85 | CHUK | 0.65786548 |
| 86 | BCKDK | 0.62474081 |
| 87 | SIK1 | 0.60682114 |
| 88 | YES1 | 0.60078920 |
| 89 | CCNB1 | 0.58363550 |
| 90 | RET | 0.56639828 |
| 91 | FGFR4 | 0.54943705 |
| 92 | MAP3K2 | 0.54770540 |
| 93 | FYN | 0.51624305 |
| 94 | MYLK | 0.48963364 |
| 95 | PRKCD | 0.48360096 |
| 96 | PRKD2 | 0.47483124 |
| 97 | KSR2 | 0.47139605 |
| 98 | TESK1 | 0.46432678 |
| 99 | ABL1 | 0.46053801 |
| 100 | DMPK | 0.46023848 |
| 101 | KDR | 0.45651411 |
| 102 | CDK6 | 0.44718837 |
| 103 | MAPK12 | 0.44507823 |
| 104 | MAP3K6 | 0.43461830 |
| 105 | PDK1 | 0.43456784 |
| 106 | MAPK7 | 0.43298663 |
| 107 | TGFBR1 | 0.42238200 |
| 108 | CDK9 | 0.41372349 |
| 109 | INSR | 0.40877992 |
| 110 | LMTK2 | 0.40839569 |
| 111 | ALK | 0.40790118 |
| 112 | MAP3K8 | 0.40768884 |
| 113 | CDC42BPA | 0.40676239 |
| 114 | RAF1 | 0.40528751 |
| 115 | PRKD1 | 0.39670510 |
| 116 | BMPR2 | 0.39564211 |
| 117 | MAP2K3 | 0.39440718 |
| 118 | PAK4 | 0.38409799 |
| 119 | MAP3K12 | 0.37106880 |
| 120 | PIK3CG | 0.36906136 |
| 121 | MAP2K1 | 0.36267287 |
| 122 | CDK12 | 0.35812098 |
| 123 | TAOK2 | 0.35232538 |
| 124 | MAPK11 | 0.34847160 |
| 125 | BMX | 0.33840796 |
| 126 | MAP3K7 | 0.33238049 |
| 127 | CSNK1A1L | 0.33233821 |
| 128 | PDK2 | 0.33190753 |
| 129 | SRC | 0.33149383 |
| 130 | CDK4 | 0.33099296 |
| 131 | CSNK1G3 | 0.31728375 |
| 132 | MAP2K6 | 0.31093599 |
| 133 | OXSR1 | 0.30528235 |
| 134 | MELK | 0.28941870 |
| 135 | MOS | 0.26603004 |
| 136 | PKN1 | 0.25606794 |
| 137 | CSNK1G1 | 0.24769340 |
| 138 | TLK1 | 0.24195858 |
| 139 | FGR | 0.23617165 |
| 140 | CHEK2 | 0.21135139 |
| 141 | MAPK4 | 0.20841395 |
| 142 | EGFR | 0.19930430 |
| 143 | MAPKAPK2 | 0.19890339 |
| 144 | JAK2 | 0.17502153 |
| 145 | TRIB3 | 0.16013049 |
| 146 | TNK2 | 0.15405282 |
| 147 | CSNK1G2 | 0.14456535 |
| 148 | CHEK1 | 0.14028691 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.88131034 |
| 2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 6.69786314 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 5.47894988 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.57317347 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.79055467 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.59181937 |
| 7 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.47743430 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.47200143 |
| 9 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.28965038 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 2.08514359 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.91626574 |
| 12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.88128232 |
| 13 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.86612180 |
| 14 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.74422153 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.71559982 |
| 16 | DNA replication_Homo sapiens_hsa03030 | 1.68559875 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.68269476 |
| 18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.61144262 |
| 19 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.58197453 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.48438248 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.45075031 |
| 22 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.43667013 |
| 23 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.42224244 |
| 24 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.38432130 |
| 25 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.36438303 |
| 26 | Mismatch repair_Homo sapiens_hsa03430 | 1.34828237 |
| 27 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.33972536 |
| 28 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.33650827 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.20857114 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.15651100 |
| 31 | Asthma_Homo sapiens_hsa05310 | 1.14919594 |
| 32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.13995096 |
| 33 | Other glycan degradation_Homo sapiens_hsa00511 | 1.10598350 |
| 34 | Phagosome_Homo sapiens_hsa04145 | 1.09025442 |
| 35 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.07500646 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.07072115 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.05051814 |
| 38 | Measles_Homo sapiens_hsa05162 | 1.04971225 |
| 39 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.03142251 |
| 40 | Ribosome_Homo sapiens_hsa03010 | 1.03080565 |
| 41 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.02866923 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.02728636 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.02474505 |
| 44 | Allograft rejection_Homo sapiens_hsa05330 | 1.01601974 |
| 45 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.98519239 |
| 46 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.97832154 |
| 47 | Homologous recombination_Homo sapiens_hsa03440 | 0.93862278 |
| 48 | Malaria_Homo sapiens_hsa05144 | 0.93609732 |
| 49 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.91830473 |
| 50 | Mineral absorption_Homo sapiens_hsa04978 | 0.90649240 |
| 51 | Viral myocarditis_Homo sapiens_hsa05416 | 0.88755054 |
| 52 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.88524504 |
| 53 | Hepatitis B_Homo sapiens_hsa05161 | 0.83929075 |
| 54 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.83774711 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83046984 |
| 56 | Proteasome_Homo sapiens_hsa03050 | 0.81014802 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80266224 |
| 58 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.77504141 |
| 59 | Shigellosis_Homo sapiens_hsa05131 | 0.76432084 |
| 60 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.76095460 |
| 61 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.75202763 |
| 62 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.74348797 |
| 63 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.72572815 |
| 64 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71181458 |
| 65 | Histidine metabolism_Homo sapiens_hsa00340 | 0.70821329 |
| 66 | Apoptosis_Homo sapiens_hsa04210 | 0.70721053 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70307767 |
| 68 | Pertussis_Homo sapiens_hsa05133 | 0.70115337 |
| 69 | Galactose metabolism_Homo sapiens_hsa00052 | 0.69904693 |
| 70 | Influenza A_Homo sapiens_hsa05164 | 0.65243536 |
| 71 | Legionellosis_Homo sapiens_hsa05134 | 0.64250570 |
| 72 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.64224652 |
| 73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62038385 |
| 74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.61624988 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61211027 |
| 76 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.60953997 |
| 77 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.60279147 |
| 78 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.59090799 |
| 79 | Platelet activation_Homo sapiens_hsa04611 | 0.58995478 |
| 80 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.58854242 |
| 81 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.58654176 |
| 82 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.57844579 |
| 83 | Amoebiasis_Homo sapiens_hsa05146 | 0.57682343 |
| 84 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.54391517 |
| 85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54142617 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.52975255 |
| 87 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.50042402 |
| 88 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.49819582 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.48704741 |
| 90 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.48608354 |
| 91 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.46893208 |
| 92 | Prion diseases_Homo sapiens_hsa05020 | 0.46310614 |
| 93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43520908 |
| 94 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.42534116 |
| 95 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.42410914 |
| 96 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42221855 |
| 97 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.41214671 |
| 98 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.40240606 |
| 99 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.39924036 |
| 100 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.39555071 |
| 101 | Sulfur relay system_Homo sapiens_hsa04122 | 0.39496141 |
| 102 | Retinol metabolism_Homo sapiens_hsa00830 | 0.37687772 |
| 103 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.37613210 |
| 104 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.37181253 |
| 105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37093280 |
| 106 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37007326 |
| 107 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.36191417 |
| 108 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.34121354 |
| 109 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.33866706 |
| 110 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.32896129 |
| 111 | Spliceosome_Homo sapiens_hsa03040 | 0.32231731 |
| 112 | Bile secretion_Homo sapiens_hsa04976 | 0.31572422 |
| 113 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.30877753 |
| 114 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.30326298 |
| 115 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.30210146 |
| 116 | Long-term potentiation_Homo sapiens_hsa04720 | 0.29461987 |
| 117 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.29183013 |
| 118 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.28886649 |
| 119 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.28052919 |
| 120 | Hepatitis C_Homo sapiens_hsa05160 | 0.27597881 |
| 121 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.27541231 |
| 122 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.27312283 |
| 123 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.26162343 |
| 124 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.24784006 |
| 125 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.24715712 |
| 126 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.24579982 |
| 127 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.23630306 |
| 128 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.22049718 |
| 129 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.22045112 |
| 130 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.21584926 |
| 131 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.20687884 |
| 132 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.20262025 |
| 133 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.19816513 |
| 134 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.19198737 |
| 135 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.18283989 |
| 136 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.18229753 |
| 137 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.15150021 |
| 138 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.13948527 |
| 139 | Salmonella infection_Homo sapiens_hsa05132 | 0.13643555 |
| 140 | Insulin resistance_Homo sapiens_hsa04931 | 0.13619094 |
| 141 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.13469324 |
| 142 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.12100466 |
| 143 | Lysosome_Homo sapiens_hsa04142 | 0.11551802 |
| 144 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.10351200 |
| 145 | Glioma_Homo sapiens_hsa05214 | 0.10190975 |

